Skip to main content
BioSyent Inc. logo

BioSyent Inc. — Investor Relations & Filings

Ticker · RX ISIN · CA0906901081 TSXV Manufacturing
Open in API
Filings indexed 182 across all filing types
Latest filing 2026-04-01 Regulatory Filings
Country CA Canada
Listing TSXV RX

About BioSyent Inc.

https://www.biosyent.com/

BioSyent Inc. is a profitable, growth-oriented specialty pharmaceutical company focused on enhancing patient lives by addressing unmet medical needs. The company's primary business model involves sourcing, in-licensing, and acquiring innovative pharmaceutical and healthcare products globally for development and commercialization. BioSyent markets a diverse portfolio of products, including prescription, over-the-counter, and behind-the-counter options, primarily serving markets in Canada and select international regions.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 0% confidence The document is a corporate press release announcing that the company’s product was named the #1 OTC iron supplement brand in Canada. It contains no financial results, voting, management changes, capital transactions, or regulatory form references. It is a general announcement and does not fit any specific filing category, so it falls into the fallback category “Regulatory Filings” (RNS).
2026-04-01 English
News release - English.pdf
Share Issue/Capital Change Classification · 1% confidence The document is a 'Form 45-106F1 Report of Exempt Distribution', which is a regulatory filing used in Canada to report the distribution of securities to investors under an exemption from the prospectus requirement. This document relates to capital raising activities and the issuance of securities. Among the provided categories, 'SHA' (Share Issue/Capital Change) is the most appropriate fit as it pertains to the issuance of shares or capital changes, and it is a standard regulatory filing for such events.
2026-01-29 English
Material change report - English.pdf
Transaction in Own Shares Classification · 1% confidence The document is a 'Material Change Report' (Form 51-102F3) filed by BioSyent Inc. regarding the renewal of a 'Normal Course Issuer Bid' (NCIB). An NCIB is a program for a company to repurchase its own shares from the open market. According to the provided filing definitions, the category 'Transaction in Own Shares' (POS) is specifically designated for reports of a company buying back or selling its own shares (share repurchase). While the document also includes a news release, the primary regulatory filing is the Material Change Report detailing the share repurchase program.
2025-12-15 English
News release - English.pdf
Transaction in Own Shares Classification · 1% confidence The document is a news release announcing the renewal of a 'Normal Course Issuer Bid' (NCIB), which is a program for a company to repurchase its own shares. This falls directly under the category of 'Transaction in Own Shares' (POS), as it details the company's intention and authorization to buy back its own stock from the market.
2025-12-15 English
News release - English.pdf
Report Publication Announcement Classification · 1% confidence The document is a press release scheduling the date for the first quarter earnings release and stating when and where the presentation will be available. No financial results are disclosed; instead, it announces the timing of the upcoming report. This fits the definition of a Report Publication Announcement rather than an actual Earnings Release or Quarterly Report.
2025-05-08 English
Notice of meeting - English.pdf
Proxy Solicitation & Information Statement Classification · 1% confidence The document is titled “Notice of our 2025 Annual General and Special Meeting of Shareholders,” provides meeting date, location, agenda items, record date, proxy submission instructions, and requests shareholder votes. It is a proxy solicitation/meeting materials notice rather than the actual AGM presentation or full financial report. This matches the Proxy Solicitation & Information Statement category (PSI).
2025-04-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.